bosutinib
E2104210
UNEXPLORED
Bosutinib is an oral tyrosine kinase inhibitor primarily used to treat Philadelphia chromosome–positive chronic myelogenous leukemia by targeting BCR-ABL and Src family kinases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| bosutinib canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.